Our previous work observed that inhibition of immunoproteasome LMP2 significantly reduced the cerebral infarction volume, attenuated inflammatory reactions, enhanced angiogenesis and improved neurological function recovery in rat stroke models [9, 10]. The gene discussed is PSMB9; the disease is brain infarction.